4D Molecular Therapeutics, Inc. Common Stock, Capital Shares Reserved for Future Issuance
4D Molecular Therapeutics, Inc. (FDMT) had Common Stock, Capital Shares Reserved for Future Issuance of 33.52 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-13
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 33.52M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 33.95M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 23.21M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 22.72M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 33.52M shares 10-Q · filed 2026-08-13 |
| 2026-03-31 | 33.95M shares 10-Q · filed 2026-05-07 |
| 2025-12-31 | 23.21M shares 10-Q · filed 2026-08-13 |
| 2025-09-30 | 22.72M shares 10-Q · filed 2025-11-10 |
| 2025-06-30 | 22.80M shares 10-Q · filed 2025-08-11 |
| 2025-03-31 | 22.89M shares 10-Q · filed 2025-05-08 |
| 2024-12-31 | 20.81M shares 10-K · filed 2026-03-18 |
| 2024-09-30 | 14.61M shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 14.69M shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 14.86M shares 10-Q · filed 2024-05-09 |
| 2023-12-31 | 9.31M shares 10-K · filed 2025-02-28 |
| 2023-09-30 | 9.64M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 9.76M shares 10-Q · filed 2023-08-09 |
| 2023-03-31 | 9.92M shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 8.36M shares 10-K · filed 2024-02-29 |
| 2022-09-30 | 8.59M shares 10-Q · filed 2022-11-08 |
| 2022-06-30 | 8.61M shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 8.72M shares 10-Q · filed 2022-05-12 |
| 2021-12-31 | 7.12M shares 10-K · filed 2023-03-15 |
| 2021-09-30 | 7.31M shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 7.58M shares 10-Q · filed 2021-08-12 |
| 2021-03-31 | 7.74M shares 10-Q · filed 2021-05-13 |
| 2020-12-31 | 6.15M shares 10-K · filed 2022-03-28 |
| 2019-12-31 | 10.04M shares 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Entera Bio Ltd. (ENTX) | $0.485B |